Stroes A, Vos M, Benninga M, Koot B
Eur J Pediatr. 2024; 184(1):29.
PMID: 39560782
DOI: 10.1007/s00431-024-05848-1.
Kim M, Han J, An J, Kim B, Jin Y, Kim S
Clin Mol Hepatol. 2024; 30(Suppl):S5-S105.
PMID: 39159947
PMC: 11493350.
DOI: 10.3350/cmh.2024.0506.
Joo J, Yoo I, Yang H
Pediatr Gastroenterol Hepatol Nutr. 2024; 27(4):236-245.
PMID: 39035406
PMC: 11254650.
DOI: 10.5223/pghn.2024.27.4.236.
Conroy C, Radulescu A, Attia S, Shelman N, Lee J, Monticelli R
Saudi J Gastroenterol. 2024; 30(4):252-259.
PMID: 38726916
PMC: 11379251.
DOI: 10.4103/sjg.sjg_428_23.
Foo R, Ma J, Du R, Goh G, Chong Y, Zhang C
EClinicalMedicine. 2024; 72:102609.
PMID: 38707911
PMC: 11067479.
DOI: 10.1016/j.eclinm.2024.102609.
Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver Disease.
Gawrieh S, Karns R, Kleiner D, Olivier M, Jenkins T, Inge T
Arch Clin Biomed Res. 2023; 7(1):112-119.
PMID: 37583647
PMC: 10426795.
DOI: 10.26502/acbr.50170323.
Utilization of Topiramate as an Adjunct to Lifestyle Intervention for Weight Loss in Pediatric Nonalcoholic Fatty Liver Disease.
Kohut T, Serai S, Panganiban J
JPGN Rep. 2023; 2(4):e126.
PMID: 37206463
PMC: 10191479.
DOI: 10.1097/PG9.0000000000000126.
A natural history study of paediatric non-alcoholic fatty liver disease over 10 years.
Draijer L, Voorhoeve M, Troelstra M, Holleboom A, Beuers U, Kusters M
JHEP Rep. 2023; 5(5):100685.
PMID: 37077274
PMC: 10106916.
DOI: 10.1016/j.jhepr.2023.100685.
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.
Hegarty R, Kyrana E, Fitzpatrick E, Dhawan A
Ther Adv Endocrinol Metab. 2023; 14:20420188231160388.
PMID: 36968656
PMC: 10034351.
DOI: 10.1177/20420188231160388.
Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity.
Hojreh A, Lischka J, Tamandl D, Ramazanova D, Mulabdic A, Greber-Platzer S
Nutrients. 2023; 15(3).
PMID: 36771265
PMC: 9921256.
DOI: 10.3390/nu15030558.
Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease.
Draijer L, Voorhoeve M, Benninga M, Koot B
Acta Paediatr. 2022; 111(12):2408-2415.
PMID: 35899429
PMC: 9804620.
DOI: 10.1111/apa.16502.
Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic.
Marginean C, Melit L, Sasaran M
Biomedicines. 2021; 9(12).
PMID: 34944682
PMC: 8698557.
DOI: 10.3390/biomedicines9121866.
Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism?.
Karhan A, Hizarcioglu-Gulsen H, Gumus E, Akcoren Z, Demir H, Saltik-Temizel I
Pediatr Gastroenterol Hepatol Nutr. 2021; 24(6):518-527.
PMID: 34796096
PMC: 8593365.
DOI: 10.5223/pghn.2021.24.6.518.
Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction.
Radulescu A, Dugan A, Killian M, Attia S, Mouzaki M, Fuchs G
Pediatr Obes. 2021; 17(3):e12862.
PMID: 34662928
PMC: 11167530.
DOI: 10.1111/ijpo.12862.
Hepatic macrosteatosis in the US pediatric deceased liver donor population.
Purvis J, Orandi B, Dhall D, McLeod C, Gutierrez Sanchez L, Gray M
Pediatr Transplant. 2021; 26(1):e14155.
PMID: 34590386
PMC: 8752486.
DOI: 10.1111/petr.14155.
Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
Gawrieh S, Harlow K, Pike F, Yates K, Wilson L, Cummings O
J Pediatr. 2021; 239:161-167.e5.
PMID: 34400208
PMC: 8922020.
DOI: 10.1016/j.jpeds.2021.08.012.
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.
Ayonrinde O
JHEP Rep. 2021; 3(3):100261.
PMID: 34036255
PMC: 8135048.
DOI: 10.1016/j.jhepr.2021.100261.
Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X
BMC Pediatr. 2021; 21(1):122.
PMID: 33711964
PMC: 7953770.
DOI: 10.1186/s12887-021-02595-2.
Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
Cairoli V, De Matteo E, Rios D, Lezama C, Galoppo M, Casciato P
Sci Rep. 2021; 11(1):5129.
PMID: 33664397
PMC: 7933421.
DOI: 10.1038/s41598-021-84674-z.
The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.
DiStefano J, Shaibi G
Pediatr Obes. 2020; 16(6):e12759.
PMID: 33305889
PMC: 8195317.
DOI: 10.1111/ijpo.12759.